Clinical Trials Directory

Trials / Completed

CompletedNCT02726958

Early Postoperative Blood Glucose Variability and Outcome After TAVI

Early Postoperative Blood Glucose Variability and Outcome After TAVI : a Retrospective Single-centre Study

Status
Completed
Phase
Study type
Observational
Enrollment
160 (actual)
Sponsor
Centre Hospitalier Universitaire de Besancon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Stress hyperglycaemia is a well-known risk factor of postoperative morbidity and mortality in cardiac surgery. Recently, several authors have reported that increased blood glucose (BG) variability could worsen the prognosis in this population.The transcatheter aortic valve implantation (TAVI) is a low invasive procedure proposed as an alternative technique to aortic valve replacement surgery in high-risk patients. The aim of this study is to describe the incidence of stress hyperglycaemia and assess whether BG variability could impact the outcome of patients undergoing TAVI.

Conditions

Timeline

Start date
2014-03-01
Primary completion
2014-06-01
Completion
2014-09-01
First posted
2016-04-04
Last updated
2017-09-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02726958. Inclusion in this directory is not an endorsement.